Samuel Stanton

Joshua Southern, Changpeng Lu, Santrupti Nerli et al.

Multispecific antibodies offer transformative therapeutic potential by engaging multiple epitopes simultaneously, yet their efficacy is an emergent property governed by complex molecular architectures. Rational design is often bottlenecked by the inability to predict how subtle changes in domain topology influence functional outcomes, a challenge exacerbated by the scarcity of comprehensive experimental data. Here, we introduce a computational framework to address part of this gap. First, we present a generative method for creating large-scale, realistic synthetic functional landscapes that capture non-linear interactions where biological activity depends on domain connectivity. Second, we propose a graph neural network architecture that explicitly encodes these topological constraints, distinguishing between format configurations that appear identical to sequence-only models. We demonstrate that this model, trained on synthetic landscapes, recapitulates complex functional properties and, via transfer learning, has the potential to achieve high predictive accuracy on limited biological datasets. We showcase the model's utility by optimizing trade-offs between efficacy and toxicity in trispecific T-cell engagers and retrieving optimal common light chains. This work provides a robust benchmarking environment for disentangling the combinatorial complexity of multispecifics, accelerating the design of next-generation therapeutics.

Aya Abdelsalam Ismail, Tuomas Oikarinen, Amy Wang et al.

We introduce Concept Bottleneck Protein Language Models (CB-pLM), a generative masked language model with a layer where each neuron corresponds to an interpretable concept. Our architecture offers three key benefits: i) Control: We can intervene on concept values to precisely control the properties of generated proteins, achieving a 3 times larger change in desired concept values compared to baselines. ii) Interpretability: A linear mapping between concept values and predicted tokens allows transparent analysis of the model's decision-making process. iii) Debugging: This transparency facilitates easy debugging of trained models. Our models achieve pre-training perplexity and downstream task performance comparable to traditional masked protein language models, demonstrating that interpretability does not compromise performance. While adaptable to any language model, we focus on masked protein language models due to their importance in drug discovery and the ability to validate our model's capabilities through real-world experiments and expert knowledge. We scale our CB-pLM from 24 million to 3 billion parameters, making them the largest Concept Bottleneck Models trained and the first capable of generative language modeling.